nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—hepatic artery—pancreatic cancer	0.323	0.476	CbGeAlD
Ximelagatran—F2—portal vein—pancreatic cancer	0.28	0.414	CbGeAlD
Ximelagatran—F2—gall bladder—pancreatic cancer	0.0481	0.071	CbGeAlD
Ximelagatran—F2—digestive system—pancreatic cancer	0.0189	0.028	CbGeAlD
Ximelagatran—CYP2C9—Tamoxifen—pancreatic cancer	0.0101	0.576	CbGbCtD
Ximelagatran—CYP2C9—digestive system—pancreatic cancer	0.00755	0.0111	CbGeAlD
Ximelagatran—CYP2C9—Fluorouracil—pancreatic cancer	0.00745	0.424	CbGbCtD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.00223	0.00732	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—SST—pancreatic cancer	0.00196	0.00643	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—FUT8—pancreatic cancer	0.00196	0.00642	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SSTR3—pancreatic cancer	0.00191	0.00625	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SSTR1—pancreatic cancer	0.00183	0.00599	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PPY—pancreatic cancer	0.00179	0.00588	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—GCG—pancreatic cancer	0.00177	0.0058	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SSTR2—pancreatic cancer	0.00176	0.00577	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00174	0.00569	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCKBR—pancreatic cancer	0.0017	0.00557	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.00169	0.00555	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.00169	0.00554	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—AGTR1—pancreatic cancer	0.00167	0.00547	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00166	0.00546	CbGpPWpGaD
Ximelagatran—F2—PAR1-mediated thrombin signaling events—PIK3CA—pancreatic cancer	0.00159	0.00522	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00158	0.00519	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—pancreatic cancer	0.00155	0.00507	CbGpPWpGaD
Ximelagatran—F2—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.00152	0.00499	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.00151	0.00495	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA5—pancreatic cancer	0.00147	0.00483	CbGpPWpGaD
Ximelagatran—F2—Platelet Aggregation (Plug Formation)—AKT1—pancreatic cancer	0.00147	0.00481	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.00146	0.00478	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—pancreatic cancer	0.00141	0.00462	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PPP2R5B—pancreatic cancer	0.00139	0.00456	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SCT—pancreatic cancer	0.00139	0.00454	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CB—pancreatic cancer	0.00134	0.00439	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCK—pancreatic cancer	0.00132	0.00433	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.00131	0.00431	CbGpPWpGaD
Ximelagatran—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00129	0.00422	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CNR2—pancreatic cancer	0.00129	0.00422	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GLP1R—pancreatic cancer	0.00129	0.00422	CbGpPWpGaD
Ximelagatran—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.00128	0.00418	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCKAR—pancreatic cancer	0.00127	0.00415	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CG—pancreatic cancer	0.00126	0.00413	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGF—pancreatic cancer	0.00125	0.00408	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TNF—pancreatic cancer	0.00124	0.00406	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00121	0.00398	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PCSK1—pancreatic cancer	0.0012	0.00392	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SHH—pancreatic cancer	0.00115	0.00379	CbGpPWpGaD
Ximelagatran—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—pancreatic cancer	0.00115	0.00378	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRLHR—pancreatic cancer	0.00115	0.00377	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—IAPP—pancreatic cancer	0.00114	0.00374	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00112	0.00367	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CD—pancreatic cancer	0.00111	0.00363	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTHLH—pancreatic cancer	0.00109	0.00359	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—PTCH1—pancreatic cancer	0.00109	0.00359	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00109	0.00359	CbGpPWpGaD
Ximelagatran—F2—Folate Metabolism—TP53—pancreatic cancer	0.00109	0.00358	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00108	0.00353	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—SRC—pancreatic cancer	0.00107	0.00352	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GDI1—pancreatic cancer	0.00105	0.00346	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GDI2—pancreatic cancer	0.00105	0.00346	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00103	0.00339	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—NRAS—pancreatic cancer	0.00103	0.00339	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PPY—pancreatic cancer	0.00101	0.00332	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—SST—pancreatic cancer	0.001	0.00328	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000994	0.00326	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000984	0.00323	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000978	0.00321	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CB—pancreatic cancer	0.000965	0.00317	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00096	0.00315	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000938	0.00308	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CNR1—pancreatic cancer	0.000924	0.00303	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPY—pancreatic cancer	0.00092	0.00302	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	0.000919	0.00301	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	0.000908	0.00298	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000903	0.00296	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GCG—pancreatic cancer	0.000892	0.00293	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—KRAS—pancreatic cancer	0.000888	0.00291	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000872	0.00286	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000851	0.00279	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CD44—pancreatic cancer	0.000832	0.00273	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GAST—pancreatic cancer	0.000826	0.00271	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—PIK3CA—pancreatic cancer	0.000816	0.00268	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	0.000808	0.00265	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA1—pancreatic cancer	0.000806	0.00264	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SCT—pancreatic cancer	0.000783	0.00257	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.000764	0.0025	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—pancreatic cancer	0.000755	0.00248	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IFNA2—pancreatic cancer	0.00075	0.00246	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GAST—pancreatic cancer	0.00075	0.00246	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCK—pancreatic cancer	0.000747	0.00245	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.000744	0.00244	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000744	0.00244	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000728	0.00239	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000728	0.00239	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000716	0.00235	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SCT—pancreatic cancer	0.000711	0.00233	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	0.000704	0.00231	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRLHR—pancreatic cancer	0.00068	0.00223	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCK—pancreatic cancer	0.000678	0.00222	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000678	0.00222	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR2—pancreatic cancer	0.000661	0.00217	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000661	0.00217	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCKAR—pancreatic cancer	0.00065	0.00213	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000645	0.00211	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.000641	0.0021	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000639	0.0021	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000639	0.0021	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GCG—pancreatic cancer	0.000628	0.00206	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000619	0.00203	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SHH—pancreatic cancer	0.000593	0.00194	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000588	0.00193	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IAPP—pancreatic cancer	0.000585	0.00192	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR3—pancreatic cancer	0.000578	0.0019	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DTX1—pancreatic cancer	0.000578	0.0019	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SST—pancreatic cancer	0.000566	0.00186	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	0.000564	0.00185	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000562	0.00184	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000562	0.00184	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000555	0.00182	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR1—pancreatic cancer	0.000554	0.00182	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	0.00055	0.0018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPY—pancreatic cancer	0.000543	0.00178	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR2—pancreatic cancer	0.000533	0.00175	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—pancreatic cancer	0.000532	0.00175	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000522	0.00171	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCKBR—pancreatic cancer	0.000515	0.00169	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SST—pancreatic cancer	0.000514	0.00169	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000512	0.00168	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000506	0.00166	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	0.000504	0.00165	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GCG—pancreatic cancer	0.000504	0.00165	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000491	0.00161	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DTX4—pancreatic cancer	0.000484	0.00159	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GLI1—pancreatic cancer	0.000484	0.00159	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000481	0.00158	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000478	0.00157	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR1—pancreatic cancer	0.000474	0.00156	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—pancreatic cancer	0.000474	0.00155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRP1—pancreatic cancer	0.000471	0.00155	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000471	0.00155	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EGF—pancreatic cancer	0.000468	0.00154	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GCG—pancreatic cancer	0.000458	0.0015	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HEY2—pancreatic cancer	0.000453	0.00149	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GAST—pancreatic cancer	0.000443	0.00145	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000439	0.00144	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000437	0.00143	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	0.000429	0.00141	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HEY1—pancreatic cancer	0.00042	0.00138	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SCT—pancreatic cancer	0.00042	0.00138	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CD—pancreatic cancer	0.000416	0.00137	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000406	0.00133	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCK—pancreatic cancer	0.000401	0.00131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR2—pancreatic cancer	0.00039	0.00128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GLP1R—pancreatic cancer	0.00039	0.00128	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—pancreatic cancer	0.00039	0.00128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCKAR—pancreatic cancer	0.000384	0.00126	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG2—pancreatic cancer	0.000372	0.00122	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MEN1—pancreatic cancer	0.000367	0.0012	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—pancreatic cancer	0.000363	0.00119	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000351	0.00115	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SHH—pancreatic cancer	0.00035	0.00115	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000348	0.00114	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IAPP—pancreatic cancer	0.000346	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTHLH—pancreatic cancer	0.000332	0.00109	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTCH1—pancreatic cancer	0.000332	0.00109	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—pancreatic cancer	0.00033	0.00108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SST—pancreatic cancer	0.000304	0.000996	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000299	0.000982	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JAG1—pancreatic cancer	0.000297	0.000974	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000296	0.00097	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—pancreatic cancer	0.000291	0.000954	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—pancreatic cancer	0.000283	0.000929	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR1—pancreatic cancer	0.00028	0.000919	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NRAS—pancreatic cancer	0.00028	0.000918	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—pancreatic cancer	0.000274	0.0009	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000272	0.000892	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GCG—pancreatic cancer	0.000271	0.000887	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000263	0.000863	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—pancreatic cancer	0.00026	0.000853	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGTR1—pancreatic cancer	0.000258	0.000847	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STK11—pancreatic cancer	0.000254	0.000834	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CTNNB1—pancreatic cancer	0.000253	0.00083	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PRSS1—pancreatic cancer	0.000248	0.000814	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—pancreatic cancer	0.000241	0.00079	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000239	0.000784	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000229	0.000752	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMAD4—pancreatic cancer	0.000223	0.000731	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—pancreatic cancer	0.000221	0.000726	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.00022	0.000723	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HES1—pancreatic cancer	0.000218	0.000714	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ARG2—pancreatic cancer	0.000215	0.000706	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—pancreatic cancer	0.000214	0.000702	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000208	0.000683	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—pancreatic cancer	0.000205	0.000671	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—pancreatic cancer	0.0002	0.000657	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—pancreatic cancer	0.000191	0.000625	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMP—pancreatic cancer	0.000188	0.000617	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—pancreatic cancer	0.000182	0.000598	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC2—pancreatic cancer	0.000182	0.000596	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—pancreatic cancer	0.000181	0.000593	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—pancreatic cancer	0.000178	0.000584	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—pancreatic cancer	0.000174	0.000572	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000166	0.000544	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000164	0.000539	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000161	0.000527	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NRAS—pancreatic cancer	0.000161	0.000527	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGF—pancreatic cancer	0.000159	0.000521	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000155	0.000509	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLP1R—pancreatic cancer	0.000152	0.000497	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—DPYD—pancreatic cancer	0.000149	0.000489	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—pancreatic cancer	0.000146	0.00048	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	0.000142	0.000464	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000141	0.000463	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00014	0.000459	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.00014	0.000459	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—pancreatic cancer	0.000138	0.000453	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000135	0.000443	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000127	0.000417	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000123	0.000404	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000123	0.000404	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—pancreatic cancer	0.000118	0.000388	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—pancreatic cancer	0.000117	0.000385	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000114	0.000375	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—pancreatic cancer	0.000113	0.000371	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—pancreatic cancer	0.00011	0.000361	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CD44—pancreatic cancer	0.00011	0.00036	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000109	0.000358	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000107	0.000352	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—pancreatic cancer	0.000107	0.000351	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000106	0.000349	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—pancreatic cancer	0.000106	0.000349	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCG—pancreatic cancer	0.000105	0.000345	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—pancreatic cancer	0.000104	0.00034	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—STK11—pancreatic cancer	9.88e-05	0.000324	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—pancreatic cancer	9.86e-05	0.000323	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—pancreatic cancer	9.61e-05	0.000315	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—pancreatic cancer	9.51e-05	0.000312	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRAS—pancreatic cancer	9.49e-05	0.000311	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.27e-05	0.000304	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—pancreatic cancer	8.84e-05	0.00029	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—pancreatic cancer	8.82e-05	0.000289	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—pancreatic cancer	8.64e-05	0.000284	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—pancreatic cancer	8.5e-05	0.000279	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—pancreatic cancer	8.17e-05	0.000268	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—pancreatic cancer	7.5e-05	0.000246	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—pancreatic cancer	7.26e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—pancreatic cancer	6.94e-05	0.000228	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—pancreatic cancer	6.91e-05	0.000227	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.54e-05	0.000215	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	6.24e-05	0.000205	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—pancreatic cancer	6.13e-05	0.000201	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.02e-05	0.000197	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.48e-05	0.00018	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.78e-05	0.000157	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.74e-05	0.000155	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.13e-05	0.000135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.91e-05	9.56e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.38e-05	7.81e-05	CbGpPWpGaD
